Traditional MedicarePrior AuthMedium impact
Erwinase® (asparaginase Erwinia chrysanthemi) (Revised)
Humana·FL, KY, SC · Oncology·Medicaid
We identified it
Jul 22, 2026
Summary
This is a revised Prior Authorization policy for Erwinase® (asparaginase Erwinia chrysanthemi) affecting Medicare and three state Medicaid programs (Florida, Kentucky, South Carolina). The billing team must implement prior authorization requirements for this specialty oncology medication to ensure claims are not denied.
Action Required
Immediately: Billing team must obtain prior authorization before submitting claims for Erwinase® for Medicare, Medicaid-Florida, Medicaid-Kentucky, and Medicaid-South Carolina members. Update billing system and EMR templates to flag Erwinase® prescriptions as requiring prior auth. Notify oncology providers of the authorization requirement. Contact Humana directly using the policy document reference (https://dctm.humana.com/Mentor/Web/v.aspx?objectID=090009298a586810) to understand specific authorization criteria, as this is a summary-only document. Claims submitted without prior authorization will be denied.